Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Evaluation of Diabetes Mellitus as a Risk Factor for Carpal Tunnel Syndrome
General Neurology
Neuroepidemiology Posters (7:00 AM-5:00 PM)
011
CTS is the most common compression neuropathy in the upper limb. While various risk factors have been linked to CTS, the role of DM remains unclear.  Previous studies have failed to consistently demonstrate a clear association due to variations in the geographic location of the study and in study design.
To assess if there is an association between diabetes mellitus (DM) and carpal tunnel syndrome (CTS) using population-based data from the United States.
We identified adult patients ≥ 18 years old who contributed data to the National Ambulatory Medical Care Survey (NAMCS) between 2006 and 2015. The outcome was carpal tunnel syndrome identified by ICD-9-CM codes (354.0 and 354.1), and the main independent variable was physician-reported diabetes status. Multivariable logistic regression was used to adjust for confounding variables. Adjusted odds ratios (aOR) and 95% confidence intervals (CI) were obtained. Stata v15 was used for all analyses.
Among patients included in this study (n = 322,092), 13.5% presented with DM while 0.55% with CTS. The unadjusted OR of having CTS among patients with diabetes was 0.92 (95% CI 0.74-1.14; p = 0.447). After adjusting for confounding variables, the association remained not statistically significant (aOR: 0.84; 95% CI 0.65-1.09; p = 0.203). Other variables independently associated with CTS included: age 50-59 (aOR: 1.91; 95% CI 1.49-2.45, p < 0.001), female gender (aOR 1.31; 95% CI 1.09-1.58, p < 0.004), and current tobacco use (aOR 1.32 ; 95% CI 1.07-1.63, p < 0.01).
We found no association between DM and CTS in adult ambulatory patients in the United States, but results should be taken in light of potential outcome misclassification. Future population-based studies utilizing a prospective study design should be conducted to investigate the association between diabetes control and CTS.
Authors/Disclosures
Jason Low
PRESENTER
Mr. Low has nothing to disclose.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file